365telugu.com online news,BENGALURU,January 29th,2026: Biopeak, a pioneer in India’s longevity and health optimization sector, has secured $2.7 million in a fresh funding round led by Nikhil Kamath via his investment firm, NKSquared. This follow-on investment underscores a growing confidence in clinical, preventive healthcare models tailored specifically for the Indian demographic.

The capital infusion is earmarked for aggressive expansion, including the launch of a new flagship center in Bengaluru. Beyond physical clinics, the funds will bolster Biopeak’s proprietary AI capabilities, diagnostic research, and the development of multidisciplinary programs aimed at extending “healthspan”—the period of life spent in good health.

ఇదీ చదవండి..కటక్‌లో మహీంద్రా సరికొత్త ట్రక్ అండ్ బస్ డీలర్‌షిప్ ప్రారంభం..

Read this also..Mahindra Expands Commercial Vehicle Footprint with New 3S Dealership in Cuttack..

Bridging the Gap in Preventive Healthcare

While India’s medical infrastructure has traditionally excelled in acute and episodic care, Biopeak is targeting the “longevity gap.” The company’s model shifts the focus from reactive treatment to a longitudinal approach, utilizing:

  • Multidisciplinary Specialist Teams: Coordinated care across various medical fields.
  • AI-Driven Insights: Proprietary technology to track health data over time.
  • India-Specific Protocols: Clinical interventions designed around local health profiles and disease patterns.

The company plans to use the new capital to deepen its research and development, particularly in protocol development and clinical governance. To support this, Biopeak is expanding its network of international advisors and institutional partners.

Read this also..Airtel Partners with Adobe to Offer Free Express Premium Access to 360 Million Users..

ఇదీ చదవండి..షామీర్‌పేటలో హోరెత్తిన ‘సుజుకి మత్సూరి’.. బైక్ ప్రేమికులతో సందడిగా చికేన్ సర్క్యూట్..

“What’s been missing is a clinical system that connects diagnostics, specialists, and follow-up into one long-term view of health,” said Rishi Pardal, Co-founder and CEO of Biopeak. “Nikhil’s continued support reflects a shared belief that longevity in India needs to be built on strong clinical foundations.”